|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/395 | |
| C07K 16/24 | |||
| A61P 9/00 | |||
| A61P 29/00 |
| (11) | Number of the document | 2919811 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13798486.0 |
| Date of filing the European patent application | 2013-11-14 | |
| (97) | Date of publication of the European application | 2015-09-23 |
| (45) | Date of publication and mention of the grant of the patent | 2018-12-26 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2013/070042 |
| Date | 2013-11-14 |
| (87) | Number | WO 2014/078502 |
| Date | 2014-05-22 |
| (30) | Number | Date | Country code |
| 201261727334 P | 2012-11-16 | US |
| (72) |
FISHMAN, Mark, US
THUREN, Tom, US
FOO, Shi Yin, US
BASSON, Craig, US
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | USE OF IL-1BETA BINDING ANTIBODIES FOR TREATING PERIPHERAL ARTERIAL DISEASE |
| USE OF IL-1BETA BINDING ANTIBODIES FOR TREATING PERIPHERAL ARTERIAL DISEASE |